ProCE Banner Activity

How Recent Data Have Influenced How I Treat Advanced Hodgkin Lymphoma

Clinical Thought
Recent studies have shifted the paradigm of how newly diagnosed advanced Hodgkin lymphoma is optimally treated for many patients. Here’s my take.

Released: September 13, 2018

Expiration: September 12, 2019

No longer available for credit.

Share

Faculty

Robert W. Chen

Robert W. Chen, MD

Associate Professor
Department of Hematology
City of Hope
Duarte, California

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Seagen

Takeda Oncology

Faculty Disclosure

Primary Author

Robert W. Chen, MD

Associate Professor
Department of Hematology
City of Hope
Duarte, California

Robert W. Chen, MD, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Merck, and Seattle Genetics and fees for non-CME/CE services from Merck and Seattle Genetics.